Covid-19 vaccine is developed to enhance immunity against coronavirus 2 (SARS‐CoV‐2). Following the COVID-19 pandemic, several health firms have produced vaccines and encountered many obstacles. The necessity of a vaccine for COVID-19 contributed to shorter deadlines that reduced traditional vaccine production timeframes for clinical testing – usually a long-term sequence phase – to protect, check effectiveness and infusion tests that run concurrently for months, possibly jeopardizing safety assurance. The accelerated production and severity of a COVID-19 vaccination will raise the hazard and failure level for a secure and effective vaccine. COVID-19 vaccines are composed of genetic material fragments of DNA and RNA, and the corpse uses the DNA/RNA instructions to make an immune system able to protect a person when a virus is encountered. Since it allows only a fragment of the virus to be produced, a weak defensive immune response could trigger that could require several shots to be injected (Suresh).
COVID-19 vaccines contain a virus that delivers an antigen virus into the bloodstream that causes the defensive system in the body. However, current levels of vector immunity may reduce the efficacy of the vaccine. In other words, instead of the antigen, the body causes an immune system response to the vectors (Centers for Disease Control and Prevention). Covid-19 vaccines are attenuated vaccines that contain a weakened virus that stimulates the immune system of the body. However, this causes harm to older persons with weak immune systems and raises many safety concerns. And the evidence on the efficacy and protection of vaccines for Covid-19 is promising. To end the pandemic, it is necessary to use all the resources available. As scientists learn more about the COVID-19 vaccine, researchers will keep updating their guidelines for protecting populations, using the most up-to-date research to minimize the spread of COVID-19.
Work Cited
Benefits of Getting a COVID-19 Vaccine.” Centres for Disease Control and Prevention, Centers for Disease Control and Prevention, www.cdc.gov/coronavirus/2019-ncov/vaccines/vaccine-benefits.html
Suresh Mahalingam, Adam Taylor. “The Pros and Cons of Different COVID Vaccine Technologies Explained.” The National Interest, The Center for the National Interest, 20 Sept. 2020, nationalinterest.org/blog/reboot/pros-and-cons-different-covid-vaccine-technologies-explained-169291
Cite This Work
To export a reference to this article please select a referencing stye below:
